CD22 - Oncidium Foundation

Y-90-Epratuzumab Tetratexan
Gallery
Y-90-Epratuzumab Tetratexan

Y-90-Epratuzumab Tetratexan

90Y-Epratuzumab tetraxetan entered the clinical phase as early as 1996. [...]

support dev2022-04-05T18:51:37+00:00

Th-227-Epratuzumab (Th-227-BAY1862864)
Gallery
Th-227-Epratuzumab (Th-227-BAY1862864)

Th-227-Epratuzumab (Th-227-BAY1862864)

227Th-Epratuzumab (227Th-BAY1862864 is a CD-22 thorium conjugate targeting relapsed or [...]

support dev2022-04-25T15:06:07+00:00